Literature DB >> 2379153

Dual mechanisms of inhibition of DNA synthesis by triciribine.

L L Wotring1, L B Townsend, L M Jones, K Z Borysko, D L Gildersleeve, W B Parker.   

Abstract

The inhibition of DNA synthesis in triciribine (TCN)-treated L1210 cells was shown to involve two mechanisms, with different concentration dependence. (a) Initiation of new replicons and possibly of Okazaki fragments was inhibited when the cells were treated with 0.1 microM TCN. The inhibition of replicon initiation was shown by the rate of alkaline elution of [3H]DNA from 15-min-[3H]thymidine-labeled cells being slower if the cells had been pretreated with TCN, indicating that the average size of actively replicating DNA strands was increased. (b) At 1 microM TCN elongation of previously initiated DNA chains was also inhibited. This conclusion was suggested by the decrease in the rate of alkaline elution of [3H]DNA, during postlabeling incubation, being less if TCN was included in the medium. The mechanism of inhibition of DNA synthesis by TCN was shown not to involve DNA strand breakage or cross-linking, inhibition of polyamine biosynthesis, inhibition of purine de novo biosynthesis, inhibition of DNA polymerase alpha or DNA primase, or inhibition of ligation of Okazaki fragments. The effects of TCN on the incorporation of [3H]thymidine into Okazaki fragments and higher molecular weight DNA suggested the possibilities of inhibition of Okazaki fragment initiation and/or DNA polymerase delta.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2379153

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  4 in total

Review 1.  Novel inhibitors of AKT: assessment of a different approach targeting the pleckstrin homology domain.

Authors:  E J Meuillet
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

2.  Inhibition of human immunodeficiency virus type 1 by triciribine involves the accessory protein nef.

Authors:  Roger G Ptak; Brian G Gentry; Tracy L Hartman; Karen M Watson; M Clayton Osterling; Robert W Buckheit; Leroy B Townsend; John C Drach
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191

3.  Phase I-II study: triciribine (tricyclic nucleoside phosphate) for metastatic breast cancer.

Authors:  K Hoffman; F A Holmes; G Fraschini; L Esparza; D Frye; M N Raber; R A Newman; G N Hortobagyi
Journal:  Cancer Chemother Pharmacol       Date:  1996       Impact factor: 3.333

4.  Initiation of human astrovirus type 1 infection was blocked by inhibitors of phosphoinositide 3-kinase.

Authors:  Shoichiro Tange; Yan Zhou; Yuko Nagakui-Noguchi; Takeshi Imai; Akira Nakanishi
Journal:  Virol J       Date:  2013-05-16       Impact factor: 4.099

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.